Hepatitis C, Chronic Clinical Trials

405 clinical trials for Hepatitis C, Chronic across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer — RECRUITING · NA
• Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) — RECRUITING
• Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan — RECRUITING
• People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents — ACTIVE_NOT_RECRUITING · PHASE4
• Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs — COMPLETED
• Linkage to Care for Persons With Hep C Infection — COMPLETED · NA
• C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV — ACTIVE_NOT_RECRUITING · PHASE3
• Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis — COMPLETED · PHASE2
• Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Programs — COMPLETED · NA
• Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected Patients — COMPLETED · PHASE2
• Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy — ACTIVE_NOT_RECRUITING · PHASE4
• Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C — COMPLETED · PHASE3
• Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC — COMPLETED · PHASE3
• Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen — COMPLETED · PHASE2
• A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV — COMPLETED · PHASE2
• Integrated Treatment of Hepatitis C Virus Infection — COMPLETED · NA
• The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study — COMPLETED · PHASE4
• An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease — COMPLETED · PHASE2
• Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir — COMPLETED · PHASE1
• Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012) — TERMINATED · PHASE2
• Grazoprevir (MK-5172) Administered With Peginterferon and Ribavirin in Treatment-Naïve Participants With Chronic Hepatitis C (MK-5172-003) — COMPLETED · PHASE2
• Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina. — OTHER
• Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C — COMPLETED · PHASE2
• Rapid HCV RNA Testing and LInkage to Care — TERMINATED · NA
• Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants — COMPLETED · PHASE2
• Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy — COMPLETED · PHASE1
• MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV — TERMINATED · PHASE4
• Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes — TERMINATED · PHASE2
• Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection — COMPLETED · PHASE2
• Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA). — OTHER · PHASE2
• Sofosbuvir/Velpatasvir in Postpartum Women With Opioid Use Disorder and Chronic Hepatitis C Infection — COMPLETED · PHASE4
• HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels — COMPLETED
• ATTIC - Access To Treat in the Community — TERMINATED · PHASE4
• Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative. — OTHER
• ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections — COMPLETED · PHASE2
• Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs — COMPLETED · PHASE1
• HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection — COMPLETED · PHASE3
• The Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection — COMPLETED · PHASE1
• Levels of Interleukin-6 andTransforming Growth Factor Beta in HCV Patients Sera — OTHER · PHASE1
• Eliminating HCV Infection Among PWUD — OTHER
• Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects — WITHDRAWN · PHASE1
• Evaluating the Chain of Addiction Care (CAC) — OTHER
• Possible Differences in HCC Course Depending on DAA Treatment — OTHER
• Direct-acting Antiviral Therapy and Reinfection Among PWID With Chronic HCV in Community-based Settings — COMPLETED
• Direct-acting Antiviral Therapy and Reinfection Among People With Chronic Hepatitis C Virus Infection and Recent Injecting Drug Use in the Prison Setting — COMPLETED
• A Trial to Assess the Effect of an Intervention Integrating Contingency Management (Financial Incentives) to Enhance Hepatitis C Treatment Uptake Following Dried Blood Spot Hepatitis C RNA Testing Among People With Recent Injecting Drug Use Attending Needle and Syringe Programs — OTHER · NA
• Impact of the Sustained Viral Response of Chronic Hepatitis c After Treatment With Direct Action Antivirals — COMPLETED
• Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children — COMPLETED · PHASE2
• Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection — COMPLETED · PHASE2
• Multidisciplinary Support Program in Chronic Hepatitis C — COMPLETED

Refine this search